111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Up 51.7% in December

111, Inc. Sponsored ADR (NASDAQ:YI) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 1,517 shares, an increase of 51.7% from the December 15th total of 1,000 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 12,774 shares, the days-to-cover ratio is presently 0.1 days. Based on an average trading volume of 12,774 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 111 in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, 111 currently has a consensus rating of “Sell”.

111 Price Performance

Shares of NASDAQ:YI traded down $0.07 during midday trading on Friday, reaching $5.65. 34,223 shares of the company’s stock were exchanged, compared to its average volume of 63,863. The stock has a market cap of $48.84 million, a price-to-earnings ratio of -6.73 and a beta of 0.51. 111 has a fifty-two week low of $2.48 and a fifty-two week high of $11.35. The firm’s 50 day simple moving average is $3.63 and its two-hundred day simple moving average is $5.13.

111 (NASDAQ:YI) last released its quarterly earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The firm had revenue of $421.49 million during the quarter.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.